Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Wädenswil/Zurich, Switzerland, and Saffron Walden, UK, 12 January 2021 – Domainex Ltd. , a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG . This instrument utilizes Grating-Coupled Interferometry  (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner. This system achieves superior

Invitation to presentation of Humana's report on fourth quarter and full year 2020

Humana's interim report for the fourth quarter and the full year 2020 results will be published at 08:00 CET on February 11, 2021. A web-cast telephone conference will be held at 09:00 CET the same day.The webcast, where CEO and President Rasmus Nerman and CFO Noora Jayasekara will present the report, will be accessible at Humana's website www.humanagroup.com. The presentation material will be published on the website before the conference starts. The webcast, and later the recorded version of the webcast, will also be available at www.financialhearings.com. To participate in the

Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer

Beactica Therapeutics AB, the Swedish drug discovery company, and University of Dundee, a top-ranked university in the UK for biological sciences, today announced a new research collaboration agreement. The two parties will work together in a project aimed at inhibiting WRN helicase, a protein with significant therapeutic potential for cancers with microsatellite instability. The collaboration will leverage core capabilities of each partner and build on the work of Professor John Rouse, on the control of chromosome stability and DNA repair in cancer. Beactica will contribute key

Gothenburg Green City Zone leads the way towards zero-emissions transportation in the near future

Currently in development, Gothenburg Green City Zone is a world first: an initiative by a number of major stakeholders including Volvo Cars to build a climate-neutral transportation system in a large geographical area of Gothenburg. New technology will be tested here to allow this part of Gothenburg to have 100% emission-free transport modes by 2030. And everyone is welcome to join in.Gothenburg and the Gothenburg region are growing, and the number of tourists and other visitors is set to double by 2030. This will bring a steady increase in demand for transportation, while at the same time

Lime Technologies CFO joins Itello Board of Directors

Stockholm, January 12, 2021 – Itello, a leading provider of Policy and Administration Systems and digital solutions for the life and pension insurance industry, has appointed Magnus Hansson to its Board of Directors. Magnus is currently Chief Financial Officer with the business software supplier Lime Technologies. He has previously held the CFO position at European House of Beds AB. Magnus has a Master’s degree from Jönköping International Business School. “Magnus is a welcome addition to our board, and he brings very relevant experience to Itello. We value his perspective on the B2B

Lime Technologies CFO joins Itello Board of Directors

Stockholm, January 12, 2021 – Itello, a leading provider of Policy and Administration Systems and digital solutions for the life and pension insurance industry, has appointed Magnus Hansson to its Board of Directors. Magnus is currently Chief Financial Officer with the business software supplier Lime Technologies. He has previously held the CFO position at European House of Beds AB. Magnus has a Master’s degree from Jönköping International Business School. “Magnus is a welcome addition to our board, and he brings very relevant experience to Itello. We value his perspective on the B2B

NCC to develop and build new headquarters for Genmab at Kontorværket in Copenhagen

The Kontorværket commercial area project developed by NCC occupies a central location in Valby, a district in central Copenhagen. Here, NCC will build Genmab’s new headquarters, which will meet high environmental standards for both the building and the area.[Illustration] Illustration: DISSING+WEITLINGGenmab A/S is a leader in the creation and development of differentiated antibody products for the treatment of cancer, with headquarters in Copenhagen, Denmark. The construction of Genmab’s new headquarters will start in April 2021 and is expected to be ready in the first quarter of 2023.

Finnair introduces one-way ticket fares for its flights within Europe

Finnair brings customers more choice and flexibility by introducing a new, one-way fare structure for its intra-Europe and domestic flights from 12 January 2021. One-way tickets with competitive fares are now available for all Finnair intra-Europe and domestic flights in all purchase channels.  “We want to offer our customers more choice and flexibility, and removing the complexity of return fare rules makes buying simpler and more transparent. Now the best fare levels will be available for all customers regardless of the length of stay in the destination. This is something our customers

The Nomination Committee’s proposal for Chair of the Board

In advance of the Nordic Entertainment Group AB (publ) (“NENT Group”) Annual General Meeting of shareholders to be held on Wednesday 19 May 2021, NENT Group Chair David Chance has decided not to stand for re-election. The NENT Group Nomination Committee proposes the election of Pernille Erenbjerg as the new Chair of the Board. Pernille Erenbjerg has served as member of the NENT Group Board since May 2020, and was previously President and CEO of TDC, a leading provider of integrated communications and entertainment solutions in Denmark and Norway. Pernille is currently Deputy Chair of

Tele2 presents expanded Group Leadership Team

Stockholm – Today Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) presents its expanded Group Leadership Team and announces the appointment of Stefan Trampus as new Executive Vice President Tele2 B2B and Yogesh Malik as new Executive Vice President CTIO.Tele2 presents its expanded Group Leadership Team which will now include two additional members representing key strategic areas. Yogesh Malik has been appointed Executive Vice President CTIO and will lead the new combined technology and IT unit. Yogesh has held many senior roles in multinational companies over the last 15 years

Apotek Hjärtat’s CEO Anders Nyberg retires

Anders Nyberg, CEO of Apotek Hjärtat, has announced his decision to retire during the fall of 2021. ICA Gruppen has initiated the process offinding a successor. Anders Nyberg will continue as CEO of Apotek Hjärtat and member of the group management of ICA Gruppen until his successor is in place.“I would like to extend a warm thank you to Anders Nyberg, who in recent years has developed Apotek Hjärtat from a challenger to a market leader. It is a journey that has included the development of a leading e-commerce, the acquisition of Min Doktor and to utilize the strength of being part of ICA

Meta-analysis updated with DIAGNODE-2 results provides further support for a precision medicine approach using Diamyd[®]

The large scale meta-analysis, previously published in August 2020, based on data from Phase III and Phase II trials in Europe and in the United States with the type 1 diabetes vaccine Diamyd[®] (GAD/alum), has been updated with data from the recenly announced (Sep 2020) European Phase IIb trial DIAGNODE-2. This meta-analysis comprises data from 627 individual patients and provides further support for a positive and statistically significant dose-dependent treatment response on the preservation of endogenous insulin production in individuals with type 1 diabetes that carry the HLA DR3-DQ2

Bactiguard launches Hydrocyn aqua in Greece

Bactiguard continues the launch of the Hydrocyn® aqua (Hydrocyn) product range in Europe by entering a new partnership with Lifecyn S.A. (Lifecyn) in Greece. The collaboration is based on an exclusive distribution agreement for Bactiguard’s Hydrocyn® aqua range, including products for advanced disinfection and wound care.“Launching the Hydrocyn product range in Greece is an important milestone. This is the first European launch since we introduced Hydrocyn in the Swedish market last year. Lifecyn has a proven track record and solid experience in marketing premium healthcare products to the

Kamux continues to expand by opening a mega store in Gothenburg

Kamux Corporation          Press release    12 January, 2021 at 9:30 Kamux continues to expand by opening a mega store in Gothenburg Kamux, a specialist in the purchase and sale of used cars, continues to grow in Sweden by opening a mega store in Gothenburg. “Kamux continues to expand with resolution in Sweden. The Gothenburg store perfectly complements our showroom network, and at the same time it will expand our offering to our customers. I am delighted that with the new store, Kamux will have a prominent presence in Gothenburg, which is the second largest city in Sweden. The

Alfa Laval acquires unique technology to strengthen its position in sustainable beer production

Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has acquired Sandymount, a US-based beverage technology company with a unique and patented membrane technology to concentrate beer. The technology in combination with Alfa Laval’s extensive product range, will open up interesting business opportunities for the company, and enable a more sustainable beer-delivery supply chain. The signing and closing date was December 31.Sandymount’s patented membrane technology, Revos™, in combination with Alfa Laval’s extensive product range for beer production, will

Latour completes acqui sition of VEGA S.R.L.

On November 17, 2020, Investment AB Latour, through its wholly owned subsidiary Latour Industries AB, signed an agreement to acquire VEGA S.R.L, a company based in the Marche region, Italy. All closing conditions have now been fulfilled and the transaction has been completed as of January 11, 2021. Göteborg, 12 January 2021 INVESTMENT AB LATOUR (PUBL)Johan Hjertonsson, CEO For further information, please contact:Björn Lenander, CEO Latour Industries AB, +46 708 19 47 36Gustav Samuelsson, Business Development Investment AB Latour, +46 735 52 55 59 Latour Industries consists

Filo Mining Provides Update on Drilling; Adds Fifth Rig at Filo Del Sol

JANUARY 12, 2021: Filo Mining Corp. (TSXV:FIL) (Nasdaq First North Growth Market: FIL)(OTCQX: FLMMF) ("Filo Mining”, or the “Company”) is pleased to provide an update on progress of the current season’s drill program at Filo del Sol. Four diamond drill rigs are now drilling at Filo, with a fifth to be added before the end of January.  Drills are currently focused on the large prospective area to the north of the Filo deposit and are targeting both extensions to the resource and areas of high potential for the discovery of new mineralization. “We are now full steam ahead with the 2020/

Medivir presents MIV-818 data at ASCO Gastrointestinal Cancers Symposium

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that a presentation entitled “Phase I study of the novel pro-drug MIV-818 in patients with hepatocellular carcinoma, intra-hepatic cholangiocarcinoma or liver metastases” will be given by Professor Jeff Evans, Director of Institute of Cancer Sciences at University of Glasgow, at the virtual ASCO Gastrointestinal Cancers Symposium (ASCO-GI). The presentation will be given on January 15, 2021, at 2 pm CET during the Hepatobiliary Cancer session (presentation number 309).  The results from the completed phase Ia intra-

Obducat launch upgraded capabilities for the EITRE® NIL product range to meet needs from emerging markets

OBDUCAT AB (publ) subsidiary Obducat Technologies AB, a leading supplier of lithography solutions based on nanoimprint lithography (NIL), announce the integration of new UV modules for the EITRE[®] product range. The new UV modules make it possible for customers to configure the Eitre tools with ultra-high UV light intensity.The continuous development and introduction of novel imprint materials create the market need for more versatile and configurable R&D tools that can be adapted to specific customer requirements. The development of new imprint materials is driven, to a large extent,

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for December 2020

Hamilton, Bermuda, January 12, 2021 Commercial update: In December 2020, the Company achieved average time charter equivalent earnings of approximately US$20,300 per day, gross. The Company’s three vessels trading on index-linked time charter earned approximately US$21,400 per day, gross, including average daily scrubber benefits of approximately US$1,600 per day. The Company’s five vessels trading on fixed time charter earned approximately US$19,700 per day, gross, including average daily scrubber benefits of approximately US$1,200 per day for three of the vessels. The Baltic 5TC

Adverty is granted second US patent for in-game ad viewability technology

Adverty AB (publ) has been granted a second patent by the United States Patent and Trademark Office for its in-game ad viewability technology. The new technical patent protects a method of determining whether an advert is considered visible in a three-dimensional gaming environment rendered on a screen - a key functionality of Adverty’s industry-leading in-game advertising platform.Adverty, the leading in-game platform for advertisers, agencies and game developers, today announces the notice of allowance for its most recent in-game ad viewability technology patent by the United States

HKScan aiming at carbon-neutral food production

HKScan has set the goal of carbon neutrality of its own industrial production by the end of 2025 and carbon neutrality of the entire food chain from farms to consumers by the end of 2040 at the latest. Climate work is carried out in all our home market areas in Finland, Sweden, the Baltics and Denmark. Achieving the targets requires both a significant reduction of emissions and an increase in carbon sinks together with contract farmers and other partners. This work is led in line with the company's own Zero Carbon climate plan.HKScan Corporation, Press Release, 12 January 2021 The Zero

There are no items matching the current filter
There are no more items matching the current filter
Back to top